Hypothesis: It is unknown whether hepatic impairment (HI) impacts pelacarsen uptake and systemic exposure. Aim: This single-dose, open-label, parallel-group, Phase 1 study (NCT05026996) assessed the ...

drug misuse and abuse. “There has also been reported cases of sexual harassment perpetuated by health workers,” he added. Dr Serebour made the remarks at the just-ended 66th Annual General ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first treatment for the rare degenerative disease Friedreich’s ataxia (FA).

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds ... at 4.8 milligrams experienced nausea in a study, the Danish biotech said Tuesday at ...

But the death of a trial participant could renew concerns about an older drug used alongside Beam's genetic ... The results disclosed Tuesday come from an abstract published online ahead of the ...

Reports of drug-related supply-chain issues were 40% less likely to result in drug shortages in Canada versus the United States, according to a study from University of Pittsburgh researchers and ...

Of 104 reports of supply chain issues with dozens of drugs, meaningful shortages were 40% less likely to occur in Canada than in the U.S., a new study found, and the difference was largely ...

In a study published today in Nature Chemical Biology, Professor David Rubinsztein, Dr Angeleen Fleming and colleagues modelled tauopathy in zebrafish and screened 1,437 drug compounds.

In patients with out-of-hospital cardiac arrest, the effectiveness of drugs such as epinephrine is highly time-dependent. An intraosseous route of drug administration may enable more rapid drug ...

The study found that average out-of-pocket costs for drugs for MS increased by 217% over a nine-year period. Costs have dropped for medications where generic versions have been introduced.

Doctors and many patients have high hopes that the drugs can do much more, and they cite observational studies leading to clinical trials now underway testing the drugs for treating addiction ...

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ brains, the company reported Wednesday, adding to evidence that ...